| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Indaptus Therapeutics, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 75K | $5.33K | $0.07 | Oct 9, 2024 | Direct |
| Molecular Templates, Inc. | Chief Medical Officer | Stock Option (right to buy) | 170K | Feb 15, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| INDP | Indaptus Therapeutics, Inc. | Oct 9, 2024 | 1 | $0 | 4 | Oct 10, 2024 | Chief Medical Officer |
| INDP | Indaptus Therapeutics, Inc. | Jan 22, 2024 | 1 | $0 | 4 | Jan 23, 2024 | Chief Medical Officer |
| INDP | Indaptus Therapeutics, Inc. | Aug 7, 2023 | 1 | $0 | 4 | Aug 7, 2023 | Chief Medical Officer |
| INDP | Indaptus Therapeutics, Inc. | Aug 7, 2023 | 0 | $0 | 3 | Aug 7, 2023 | Chief Medical Officer |
| MTEM | Molecular Templates, Inc. | Feb 15, 2023 | 1 | $0 | 4 | Feb 17, 2023 | Chief Medical Officer |
| MTEM | Molecular Templates, Inc. | Feb 15, 2022 | 1 | $0 | 4 | Feb 17, 2022 | Chief Medical Officer |